NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Operating Margin (2019 - 2020)

Updated

NextCure (NXTC) posted Operating Margin of -184.22% for FY2020, up 406.33 percentage points from -590.55% in FY2019.

Analysis

NextCure (NXTC) Operating Margin (2019 - 2020) Analysis & Trends

  • Business Quant data shows NXTC's Operating Margin at -590.55% in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 24.35%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 36.01%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 30.74%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 29.12%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 35.79%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 41.71%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 32.98%
10 NextCure 29.30 Mn -71.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 36.70%
Dec 31, 2019 -599.00%
Sep 30, 2019 -612.89%
Jun 30, 2019 -638.73%
Mar 31, 2019 -502.21%
API Access

NextCure Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=NXTC&period=max&api_key=YOUR_API_KEY